Human Metabotropic Glutamate Receptor 5 Antibodies Alter Receptor Levels and Behavior in Mice.
Estibaliz MaudesFrancesco MannaraAnna García-SerraMarija RadosevicAraceli MelladoAna Beatriz SerafimJesús PlanagumàLidia SabaterJosep O DalmauMarianna SpatolaPublished in: Annals of neurology (2022)
Ophelia syndrome or encephalitis with antibodies against the metabotropic glutamate receptor 5 (mGluR5) manifests with behavioral changes, memory deficits, and anxiety. To study the antibody pathogenicity, mice received continuous cerebroventricular infusion of patients' or controls' immunoglobulin G (IgG) for 14 days, followed by a 15-day washout. The effects on hippocampal mGluR5 clusters were determined by confocal microscopy. Animals infused with patients' IgG, but not controls' IgG, showed memory impairment, increased anxiety, and decreased neuronal surface mGluR5 clusters. After antibody clearance, both behavioral and molecular changes reversed to baseline conditions. These findings support the pathogenicity of these antibodies in anti-mGluR5 encephalitis. ANN NEUROL 2022;92:81-86.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- endothelial cells
- peritoneal dialysis
- low dose
- traumatic brain injury
- escherichia coli
- metabolic syndrome
- adipose tissue
- cystic fibrosis
- staphylococcus aureus
- pseudomonas aeruginosa
- sleep quality
- brain injury
- skeletal muscle
- binding protein
- subarachnoid hemorrhage
- induced pluripotent stem cells